These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 652668)

  • 1. [Biochemistry of cytotoxicity of amethopterin (author's transl)].
    Manteuffel-Cymborowska M
    Postepy Biochem; 1978; 24(1):93-115. PubMed ID: 652668
    [No Abstract]   [Full Text] [Related]  

  • 2. Recent concepts on the mechanism of action of methotrexate.
    White JC
    Cancer Treat Rep; 1981; 65 Suppl 1():3-12. PubMed ID: 7326663
    [No Abstract]   [Full Text] [Related]  

  • 3. Selection and characterization of mutant strains of Streptococcus faecium var. durans resistant to methasquin and amethopterin.
    Rader JI; Hutchison DJ
    Cancer Res; 1972 Apr; 32(4):688-95. PubMed ID: 5014779
    [No Abstract]   [Full Text] [Related]  

  • 4. [Evaluation of biochemical criteria for sensitivity of tumor cells to methotrexate by means of mathematic simulation].
    Belousova AK; Gerasimova GK; Vorontsov IN; Greshilov MM
    Biokhimiia; 1980 Apr; 45(4):609-21. PubMed ID: 6769505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A basis for fluoropyrimidine-induced antagonism to methotrexate in Ehrlich ascites tumor cells in vitro.
    Bowen D; White JC; Goldman ID
    Cancer Res; 1978 Jan; 38(1):219-22. PubMed ID: 618577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Repair replication in synchronous Ehrlich ascites cells after reversal of a methotrexate block (author's transl)].
    Probst H; Maisenbacher J
    Hoppe Seylers Z Physiol Chem; 1975 Jun; 356(6):625-33. PubMed ID: 1181264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of methotrexate on cellular metabolism: some critical elements in the drug-cell interaction.
    Goldman ID
    Cancer Treat Rep; 1977 Jul; 61(4):549-58. PubMed ID: 884691
    [No Abstract]   [Full Text] [Related]  

  • 8. [Mathematical description and study of the folic acid cycle reactions].
    Vorontsov IN; Greshilov MM; Belousova AK; Gerasimova GK
    Biokhimiia; 1980 Jan; 45(1):83-97. PubMed ID: 6783126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the role of membrane transport and polyglutamation of methotrexate in gut and the Ehrlich tumor in vivo as factors in drug sensitivity and selectivity.
    Fry DW; Anderson LA; Borst M; Goldman ID
    Cancer Res; 1983 Mar; 43(3):1087-92. PubMed ID: 6186369
    [No Abstract]   [Full Text] [Related]  

  • 10. Mechanism of action of methotrexate. IV. Free intracellular methotrexate required to suppress dihydrofolate reduction to tetrahydrofolate by Ehrlich ascites tumor cells in vitro.
    White JC; Goldman ID
    Mol Pharmacol; 1976 Sep; 12(5):711-9. PubMed ID: 1033456
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of 2,4-dinitrophenol and other metabolic inhibitors on the bidirectional carrier fluxes, net transport, and intracellular binding of methotrexate in Ehrlich ascites tumor cells.
    Fry DW; White JC; Goldman ID
    Cancer Res; 1980 Oct; 40(10):3669-73. PubMed ID: 7438050
    [No Abstract]   [Full Text] [Related]  

  • 12. Amethopterin transport in Ehrlich ascites carcinoma and L1210 cells.
    Kessel D; Hall TC
    Cancer Res; 1967 Sep; 27(9):1539-43. PubMed ID: 6051269
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of a new synthetic C-nucleoside on the growth of Ehrlich ascites tumor cells. (author's transl)].
    de la Fuente M; Barriga C; Alonso A; Peña J
    Arch Farmacol Toxicol; 1980 Dec; 6(3):247-54. PubMed ID: 6796007
    [No Abstract]   [Full Text] [Related]  

  • 14. Functional activity of the reduced folate carrier in KB, MA104, and IGROV-I cells expressing folate-binding protein.
    Westerhof GR; Rijnboutt S; Schornagel JH; Pinedo HM; Peters GJ; Jansen G
    Cancer Res; 1995 Sep; 55(17):3795-802. PubMed ID: 7641196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of growth inhibition by methotrexate.
    McBurney MW; Whitmore GF
    Cancer Res; 1975 Mar; 35(3):586-90. PubMed ID: 1167807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of nucleoside uptake into Ehrlich ascites carcinoma cells by new cytostatic methylhydrazones.
    Braun R; Dittmar W
    Cancer Res; 1978 Oct; 38(10):3512-7. PubMed ID: 688236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tumor specific factors of the placenta and cell proliferation (author's transl)].
    Letnansky K
    Exp Pathol (Jena); 1974; 9(5-6):354-60. PubMed ID: 4442508
    [No Abstract]   [Full Text] [Related]  

  • 18. Impact of polyglutamation on sensitivity to raltitrexed and methotrexate in relation to drug-induced inhibition of de novo thymidylate and purine biosynthesis in CCRF-CEM cell lines.
    Barnes MJ; Estlin EJ; Taylor GA; Aherne GW; Hardcastle A; McGuire JJ; Calvete JA; Lunec J; Pearson AD; Newell DR
    Clin Cancer Res; 1999 Sep; 5(9):2548-58. PubMed ID: 10499632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of folate antagonists on the metabolism of folic acid and its reduced derivatives in rat liver and kidney.
    Bühring U; Shin YS; Fölsch E
    Cancer Res; 1977 Jan; 37(1):299-304. PubMed ID: 830415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzyme inhibition, polyglutamation, and the effect of LY231514 (MTA) on purine biosynthesis.
    Mendelsohn LG; Shih C; Chen VJ; Habeck LL; Gates SB; Shackelford KA
    Semin Oncol; 1999 Apr; 26(2 Suppl 6):42-7. PubMed ID: 10598554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.